Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Avita Medical Ltd

RCEL
Current price
10.26 USD +0.56 USD (+5.77%)
Last closed 9.7 USD
ISIN US05380C1027
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 229 748 944 USD
Yield for 12 month -33.12 %
1Y
3Y
5Y
10Y
15Y
RCEL
21.11.2021 - 28.11.2021

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California. Address: 28159 Avenue Stanford, Valencia, CA, United States, 91355

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

15.2 USD

P/E ratio

Dividend Yield

Current Year

+50 143 000 USD

Last Year

+50 561 006 USD

Current Quarter

+15 195 000 USD

Last Quarter

+11 104 000 USD

Current Year

+42 363 000 USD

Last Year

+41 687 382 USD

Current Quarter

+13 084 000 USD

Last Quarter

+9 591 000 USD

Key Figures RCEL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -53 549 000 USD
Operating Margin TTM -102.69 %
PE Ratio
Return On Assets TTM -38.98 %
PEG Ratio
Return On Equity TTM -107.66 %
Wall Street Target Price 15.2 USD
Revenue TTM 54 139 000 USD
Book Value 0.92 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 29.3 %
Dividend Yield
Gross Profit TTM 28 380 000 USD
Earnings per share -1.94 USD
Diluted Eps TTM -1.94 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -92.04 %

Dividend Analytics RCEL

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History RCEL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:5
Payout Ratio
Last Split Date 30.06.2020
Dividend Date

Stock Valuation RCEL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 4.0829
Price Sales TTM 4.2437
Enterprise Value EBITDA -6.1664
Price Book MRQ 9.6178

Financials RCEL

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators RCEL

For 52 weeks

7.51 USD 18.93 USD
50 Day MA 9.06 USD
Shares Short Prior Month 1 863 791
200 Day MA 11.84 USD
Short Ratio 8.95
Shares Short 1 623 164
Short Percent 6.28 %